Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 21, 2020

SELL
$79.55 - $124.22 $269,594 - $420,981
-3,389 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$71.37 - $96.85 $290,975 - $394,857
-4,077 Reduced 54.61%
3,389 $286,000
Q4 2019

Jan 17, 2020

BUY
$64.27 - $86.37 $15,489 - $20,815
241 Added 3.34%
7,466 $631,000
Q3 2019

Oct 17, 2019

BUY
$67.4 - $85.11 $131,362 - $165,879
1,949 Added 36.94%
7,225 $487,000
Q2 2019

Jul 23, 2019

BUY
$80.35 - $93.9 $47,085 - $55,025
586 Added 12.49%
5,276 $452,000
Q1 2019

May 13, 2019

BUY
$84.2 - $98.62 $23,491 - $27,514
279 Added 6.33%
4,690 $417,000
Q4 2018

Feb 06, 2019

SELL
$80.14 - $106.07 $20,756 - $27,472
-259 Reduced 5.55%
4,411 $376,000
Q3 2018

Nov 13, 2018

SELL
$93.92 - $105.72 $446,589 - $502,698
-4,755 Reduced 50.45%
4,670 $453,000
Q2 2018

Aug 10, 2018

SELL
$76.01 - $99.03 $103,297 - $134,581
-1,359 Reduced 12.6%
9,425 $888,000
Q1 2018

May 01, 2018

BUY
$77.67 - $92.63 $290,408 - $346,343
3,739 Added 53.07%
10,784 $874,000
Q4 2017

Jan 26, 2018

BUY
$80.76 - $95.13 $337,173 - $397,167
4,175 Added 145.47%
7,045 $628,000
Q3 2017

Nov 13, 2017

SELL
$80.6 - $94.95 $104,135 - $122,675
-1,292 Reduced 31.04%
2,870 $267,000
Q2 2017

Aug 09, 2017

BUY
N/A
4,162
4,162 $378,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.